Read More 1 minute read Funding News News Trace Neuroscience Launches with $101M to Target ALS and Neurodegenerative Diseases Key Highlights $101M Series A funding led by Third Rock Ventures and others, supporting ALS and neurodegenerative therapies. UNC13A-focused… byChris-Anne RoqueNovember 15, 2024
Read More 1 minute read Hiring News News Judo Bio Secures $100M Financing to Advance Kidney-Targeted Oligonucleotide Medicines Key Highlights Judo Bio secures $100M in initial financing for kidney-targeted medicines. Series A co-led by Atlas Venture, TCG, and… byChris-Anne RoqueOctober 10, 2024
Read More 2 minute read Funding News News Therapeutics GRO Biosciences Secures $60.3M in Series B Financing to Advance Protein Therapeutics Key Highlights GRO Biosciences raises $60.3M in Series B financing. Funds to advance lead program for refractory gout… byChris-Anne RoqueJuly 24, 2024
Read More 1 minute read M&A News News Pharmaceutical Mariana Oncology Acquired by Novartis for $1.75 Billion Key Highlights $1 billion upfront, with up to $750 million in potential milestones for Mariana Oncology’s acquisition. Mariana Oncology’s… byChris-Anne RoqueMay 6, 2024